“The evidence would suggest that perhaps we need to investigate this pathway and perhaps this drug in both Parkinson’s, ...

Nilotinib (Tasigna) — a drug for myeloid leukemia — improved biomarkers and cognitive outcomes in study participants with dementia with Lewy bodies, a new study finds.

Other causes may include vascular dementia, Lewy body dementia, brain injuries, and certain underlying health conditions. Major neurocognitive disorder, also known as dementia, is a ...

MALVERN, Pa., Nov. 12, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ('Annovis' or the 'Company'), a late-stage clinical ...

The chronic myeloid leukemia drug nilotinib (Tasigna) improved biomarkers and cognitive outcomes in people with dementia with ...

Feeling sleepy and less enthusiastic during the day may indicate a higher risk of developing a syndrome that often leads to ...

Analyst Sumant Kulkarni of Canaccord Genuity maintained a Buy rating on CervoMed (CRVO – Research Report), retaining the price target of ...

Lewy body dementia (LBD) is a progressive neurodegenerative disease that shares traits with both Parkinson's disease and Alzheimer's disease but can be more difficult to diagnose. Lewy bodies ...

It’s a broad term that covers the effects on people of a number of different medical conditions, including Alzheimer’s disease, vascular dementia, the Lewy body dementias and more. The effects ...

"It's well known that sleep disturbances such as REM sleep behavior disorder can be early predictors of conditions including Lewy body dementia or Parkinson's disease, Isaacson said.Monitoring ...